Alerts will be sent to your verified email
Verify Email
PARMAX
|
Parmax Pharma
|
Medistep Healthcare
|
Gujarat Terce Labs.
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
24.13 % | 24.77 % | 2.73 % |
|
5yr average Equity Multiplier
|
29.23 | 1.32 | 3.3 |
|
5yr Average Asset Turnover Ratio
|
1.05 | 2.13 | 1.76 |
|
5yr Avg Net Profit Margin
|
-11.29 % | 8.79 % | -2.57 % |
|
Price to Book
|
0.0 | 0.0 | 2.78 |
|
P/E
|
0.0 | 4.73 | 12.19 |
|
5yr Avg Cash Conversion Cycle
|
-92.25 Days | 115.71 Days | -20.6 Days |
|
Inventory Days
|
69.37 Days | 9.08 Days | 40.01 Days |
|
Days Receivable
|
20.01 Days | 124.47 Days | 39.02 Days |
|
Days Payable
|
296.94 Days | 17.5 Days | 100.7 Days |
|
5yr Average Interest Coverage Ratio
|
-0.77 | 96.98 | 1.07 |
|
5yr Avg ROCE
|
-14.3 % | 33.38 % | 3.46 % |
|
5yr Avg Operating Profit Margin
|
2.43 % | 11.92 % | -0.49 % |
|
5 yr average Debt to Equity
|
10.96 | 0.04 | 0.63 |
|
5yr CAGR Net Profit
|
n/a | 35.1 % | -17.21 % |
|
5yr Average Return on Assets
|
-9.05 % | 18.77 % | -3.57 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
30.8 % | 68.96 % | 40.03 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | 0.0 | 3.58 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Parmax Pharma
|
Medistep Healthcare
|
Gujarat Terce Labs.
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|